Education
About Us
Working with TipRanks
Follow Us
Matthew J Leonard Insider Profile
4 Followers
Matthew J Leonard , See Remarks at Covetrus, holds ― shares in Covetrus (Ticker: CVET), holds 6.86K shares in ANI Pharmaceuticals (Ticker: ANIP). Most recently, Matthew J Leonard ― shares of Covetrus on ― for an estimated value of ―.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-2.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Matthew J Leonard 's holdings
Insider Roles
Director
Roles that Matthew J Leonard holds in companies
Most Profitable Insider Trade
The most profitable trade made by Matthew J Leonard
Matthew J Leonard 's Trading History
Covetrus
―
―
―
―
ANI Pharmaceuticals
Aug 26, 2025
Director
Informative Sell
229.09K
$654.48K
List of latest transactions for each holding click on a transaction to see Matthew J Leonard 's performance on stock
You May Also Like
Matthew J Leonard insider profile FAQ
What is the percentage of profitable transactions made by Matthew J Leonard ?
The percentage of profitable transactions made by Matthew J Leonard is 0%.
What is the average return per transaction made by Matthew J Leonard ?
The average return per transaction made by Matthew J Leonard is -2.90%.
What stocks does Matthew J Leonard hold?
Matthew J Leonard holds: CVET, ANIP stocks.
What was Matthew J Leonard ’s latest transaction?
Matthew J Leonard latest transaction was an Uninformative Buy of ―.
What was Matthew J Leonard 's most profitable transaction?
Matthew J Leonard ’s most profitable transaction was an Informative Sell of ANIP stock on August 26, 2025. The return on the trade was -1.70%.
What is Matthew J Leonard 's role in Covetrus?
Matthew J Leonard 's role in Covetrus is See Remarks.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.